EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,059,539 | +2.3% | 67,187 | +26.1% | 0.03% | 0.0% |
| Q2 2023 | $1,035,705 | +140.8% | 53,277 | +251.5% | 0.03% | +125.0% |
| Q1 2023 | $430,032 | -6.5% | 15,158 | +37.5% | 0.01% | -71.4% |
| Q1 2021 | $460,000 | -42.9% | 11,027 | -41.8% | 0.04% | -19.2% |
| Q3 2020 | $805,000 | -11.3% | 18,954 | -4.0% | 0.05% | -21.2% |
| Q1 2020 | $908,000 | +105.4% | 19,739 | +125.5% | 0.07% | +112.9% |
| Q1 2019 | $442,000 | -48.7% | 8,753 | -59.1% | 0.03% | -42.6% |
| Q4 2018 | $862,000 | +254.7% | 21,405 | +510.2% | 0.05% | +200.0% |
| Q3 2018 | $243,000 | – | 3,508 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |